MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cognition Therapeutics (CGTX) Earnings Date & Reports

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina... Show more

A.I. Advisor
published Earnings

CGTX is expected to report earnings to fall 18.18% to -9 cents per share on November 12

Cognition Therapeutics CGTX Stock Earnings Reports
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.02
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 1.01M shares outstanding, the current market capitalization sits at 46.77M.
View a ticker or compare two or three
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGTX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com